유전자 변이 폐암, 치료제 발전하며 생존 기간 늘었습니다 | 건강똑똑

Even with successful surgery, lung cancer has a high recurrence rate. The five-year recurrence rate after surgery has been confirmed to be around 50%, depending on the stage. Post-operative management is crucial to reducing the recurrence rate. For lung cancer with genetic mutations, targeted therapies or proven cytotoxic anticancer agents can yield high treatment outcomes. In this Health Smart Talk Show, Professor Park Byeong-jo of the Department of Thoracic and Cardiovascular Surgery, Professor Kim Hye-ryun (Director of the Lung Cancer Center), Professor Hong Min-hee, and Professor Yeo Ja-hyeon of the Department of Oncology at Yonsei Cancer Center answered the audience's questions about the latest lung cancer treatments, advancements in surgical techniques, and treatment strategies for long-term survival after lung cancer surgery. They provided detailed answers to questions such as, "Is reoperation possible if lung cancer relapses after surgery?" and "What lung cancer treatments have recently shown promising results?" /Health Chosun Video Team [email protected]